chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes, Vaccination site pain
Clinical narrative: Oral herpes outbreak 3 days post dose.; Slight injection site soreness; This is a spontaneous report from a contactable physician, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patients' medical history and concomitant medications were not reported. The patient had no known drug allergies. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 14Mar2021 at 13:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 09Apr2021, the patient experienced an oral herpes outbreak 3 days post dose with no other side effects (including fever), with the exception of slight injection site soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of oral herpes outbreak and included treatment with valacyclovir. The clinical outcome of the event oral herpes outbreak and slight injection site soreness was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Myalgia, Pain
Clinical narrative: Body ache; Fatigue; Muscle pain; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history included diabetes type 2 and the patient had a history of allergy to sulfa drugs. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) from an unknown date taken for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 59-year-old) at 14:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 00:00, the patient experienced fatigue, body ache, muscle pain and diarrhoea. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, body ache, muscle pain and diarrhoea was recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Pain
Clinical narrative: Dizziness; Nausea; Body aches; Fatigue; Light headedness; This is a spontaneous report from a contactable consumer. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 08Apr2021 at 10:30(at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tree nuts and shellfish. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 17Mar2021(at the age of 21-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 20:00, the patient experienced dizziness, nausea, body aches, fatigue and light headedness. No therapeutic measures were taken as a result of adverse events. The clinical outcome of the event dizziness, nausea, body aches, fatigue and light headedness were recovering.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: Left Arm pit and into the breast very tender; Left Arm pit and into the breast swollen; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ew0150), via an unspecified route of administration in the left arm on 01Apr2021 at 12:45 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. Medical history included weight loss and the patient did not have any allergies to medications, food or other products. Concomitant medications included unspecified allergy injections and global camellia sinensis (GREEN TEA) for weight loss from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: en6207), via an unspecified route of administration in the left arm on 11Mar2021 at 12:45 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. On 04Apr2021, the patient experienced left arm pit and into the breast very tender and swollen for about 3 days after shot. The patient also reported that the tenderness did not show up until 3 days after shot and lasted for about 3 days. No therapeutic measures were taken as the result of adverse events. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events left arm pit and into the breast very tender and swollen was recovered on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Neck pain
Clinical narrative: Severe neck pain; Severe ear pain; This is a spontaneous report from a contactable consumer. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration on 19Mar2021 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether the patient received any other vaccines within four weeks. On 09Apr2021 the patient experienced severe neck and ear pain. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events severe neck and ear pain were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 at 08:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included polycystic ovarian syndrome (PCOS). Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) from an unknown start date for an unknown indication. The patient previously used lavender oil and experienced allergy to it. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Mar2021 at 12:00, the patient experienced headache. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event headache was recovered after the duration of 24 hours.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: 20 hrs. post injection - temp 100.5, 2 hrs. later extreme chills temp 102.5,1 hr. later temp 102.6; Extreme chills; This is a spontaneous report from a contactable consumer. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737), via an unspecified route of administration in the left arm on 08Apr2021 at 14:45 (at the age of 60-year-old), as a single dose for COVID-19 immunisation. Medical history included HTN (hypertension), hypercholesterolemia and BPH (benign prostatic hyperplasia) and the patient did not had any known drug allergies. Concomitant medications include amlodipine (MANUFACTURER UNKNOWN), lovastatin (MANUFACTURER UNKNOWN), Alfuzosin HCL ER (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN) received on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6995), via an unspecified route of administration in the left arm on 18Mar2021 at 14:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 11:45, 20 hours post injection, the patient experienced temperature of 100.5 (unspecified units) and took 600 mg (milligrams) of motrin, two hours later the patient had extreme chills with temperature of 102.5 and took acetaminophen 500 mg and after 1 hour, the patient had temperature of 102.6. Therapeutic measures were taken as a result of the events which included treatment with 600mg motrin, acetaminophen 500mg and Tylenol. The patient underwent lab test on 09Apr2021 which included body temperature test and the result was 100.5(unspecified units) at 11:45, after 2 hours it was 102.5(unspecified units) and 1 hour it was 102.6(unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of high temperature and extreme chills were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Headache, Hypoaesthesia
Clinical narrative: Intermittent racing/pounding heart - started about 2 weeks after shot; Back pain started about 2 weeks after shot; Grip and hand weakness in grasping items started about 2 week after shot; Headaches - started on Day 1 and comes and goes; Extreme tiredness that comes and goes - started on Day 1; Joint pain - started on day 1 and stopped about day 3; Tingling and numbness started 3 days after first shot and occurs various places in the body; Tingling and numbness started 3 days after first shot and occurs various places in the body; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 26Mar2021 at 09:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus (lupus syndrome), hypothyroid, alopecia, atopic dermatitis, rosacea, penicillin allergy, egg allergy and dairy allergy (milk allergy). Concomitant medications included levothyroxine sodium (SYNTHYROID), cetirizine hydrochloride (ZYRTEC) and vitamin d nos (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received aspirin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, on day1 the patient experienced headaches which were coming and going, extreme tiredness which were coming and going and joint pain which stopped about day3. On an unknown date in Mar2021,3 days after the first shot, the patient had tingling and numbness occurring in various places in the body. On an unknown date in Apr2021, 2 weeks after the vaccination, the patient experienced Intermittent racing/pounding heart, back pain, grip and hand weakness in grasping items. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of joint pain was recovered on an unknown date in Mar2021 after the duration of 3 days; while that of the events headache, extreme tiredness, tingling and numbness occurring in various places in the body, intermittent racing/pounding heart, back pain, grip and hand weakness were unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Palpitations, Paraesthesia
Clinical narrative: Intermittent racing/pounding heart - started about 2 weeks after shot; Back pain started about 2 weeks after shot; Grip and hand weakness in grasping items started about 2 week after shot; Headaches - started on Day 1 and comes and goes; Extreme tiredness that comes and goes - started on Day 1; Joint pain - started on day 1 and stopped about day 3; Tingling and numbness started 3 days after first shot and occurs various places in the body; Tingling and numbness started 3 days after first shot and occurs various places in the body; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 26Mar2021 at 09:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus (lupus syndrome), hypothyroid, alopecia, atopic dermatitis, rosacea, penicillin allergy, egg allergy and dairy allergy (milk allergy). Concomitant medications included levothyroxine sodium (SYNTHYROID), cetirizine hydrochloride (ZYRTEC) and vitamin d nos (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received aspirin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, on day1 the patient experienced headaches which were coming and going, extreme tiredness which were coming and going and joint pain which stopped about day3. On an unknown date in Mar2021,3 days after the first shot, the patient had tingling and numbness occurring in various places in the body. On an unknown date in Apr2021, 2 weeks after the vaccination, the patient experienced Intermittent racing/pounding heart, back pain, grip and hand weakness in grasping items. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of joint pain was recovered on an unknown date in Mar2021 after the duration of 3 days; while that of the events headache, extreme tiredness, tingling and numbness occurring in various places in the body, intermittent racing/pounding heart, back pain, grip and hand weakness were unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Sleepy; This is a spontaneous report from a non-contactable consumer. A female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 08Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown whether the patient was pregnant. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021, the patient experienced sleepy a few hours after the vaccine was administered. No therapeutic measures were taken for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sleepy was recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Face, neck and chest are numb; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 07Apr2021 at 15:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disorder (Thyroid disease) from an unspecified date. The patient had no known allergies. Concomitant medications included levothyroxine; liothyronine (NP THYROID); liothyronine (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D), riboflavin (VITAMIN B2), pantothenic acid (VITAMIN B5), pyridoxine hydrochloride (VITAMIN B6), multivitamin (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 13:00 the patient experienced face, neck and chest were numb. No swelling or hives. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event numbness was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Swollen left armpit/lymph node; Headache; Low grade fever; Sore throat; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 07Apr2021 at 15:30(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 17Mar2021 at 15:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation and took Morphine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 03:00 the patient experienced swollen left armpit/lymph node, headache, low grade fever, sore throat and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event swollen left armpit/lymph node, headache, low grade fever, sore throat and  body aches was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Eye pain, Fatigue, Headache, Lymphadenopathy
Clinical narrative: Pain above eye sockets; Quick sharp localized pains in head; Pain mostly on side of injection; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Mar2021 at 15:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included immune thrombocytopenic purpura and cholesterol high. Concomitant medications included cetirizine hydrochloride (ZYRTEC), atorvastatin calcium (LIPITOR), vitamin d nos (VIT D) and ibuprofen (ADVIL); all from an unknown date for an unknown indication. The patient had no known allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 17Feb2021 at 15:30 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On10Mar2021, second night after second dose, the patient experienced tiredness and confusion. On an unknown date in Mar2021, 1-2 weeks after second dose, the patient experienced swollen lymph nodes, quick sharp localized pains in head, pain above eye sockets and pain mostly on side of injection. On an unknown date in Mar2021, the patient underwent rapid test (nasal swab) and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events tiredness, confusion, swollen lymph nodes, quick sharp localized pains in head, pain above eye sockets and pain mostly on side of injection were recovered on an unknown date.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test
Clinical narrative: Pain above eye sockets; Quick sharp localized pains in head; Pain mostly on side of injection; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Mar2021 at 15:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included immune thrombocytopenic purpura and cholesterol high. Concomitant medications included cetirizine hydrochloride (ZYRTEC), atorvastatin calcium (LIPITOR), vitamin d nos (VIT D) and ibuprofen (ADVIL); all from an unknown date for an unknown indication. The patient had no known allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 17Feb2021 at 15:30 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On10Mar2021, second night after second dose, the patient experienced tiredness and confusion. On an unknown date in Mar2021, 1-2 weeks after second dose, the patient experienced swollen lymph nodes, quick sharp localized pains in head, pain above eye sockets and pain mostly on side of injection. On an unknown date in Mar2021, the patient underwent rapid test (nasal swab) and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events tiredness, confusion, swollen lymph nodes, quick sharp localized pains in head, pain above eye sockets and pain mostly on side of injection were recovered on an unknown date.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Eye swelling, Pruritus
Clinical narrative: Swollen eyes; Face bright red; Face burning; Face and neck started to itch; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 05Apr2021 at 13:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included breast cancer, hypothyroidism and bipolar 2. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), lamotrigine (LAMICTAL) and clonazepam (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 14:30, 48 hours after the vaccination, the patient experienced face and neck started to itch. On 08Apr2021, following morning, patient woke up with swollen eyes, face bright red, itching, and burning. Therapeutic measures were taken as a result of adverse events and included treatment with benadryl and steroids. The clinical outcome of the event face and neck started to itch, swollen eyes, face bright red, face burning was recovering at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Cold sweat, Diarrhoea, Fatigue
Clinical narrative: abdominal cramping; diarrhea; nausea; hot and cold sweats; hot and cold sweats; 99.1F temperature; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 08Apr2021 at 11:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included family history of Irritable Bowel Syndrome (IBS), heart disease and cancer and the patient was diagnosed with depression and anxiety and was allergic to red onions. Concomitant medications included propranolol (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN), drospirenone, ethinylestradiol betadex clathrate (YAZ) and bupropion (MANUFACTURER UNKNOWN), all taken from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 23:45, 12 hours after the vaccination, the patient experienced 40 minutes of extreme abdominal cramping, diarrhea, nausea, hot and cold sweats and 99.1 Fahrenheit temperature followed by fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event abdominal cramps was resolved on 09Apr2021, while the outcome of the events diarrhea, nausea, hot and cold sweats and 99.1 Fahrenheit temperature followed by fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: abdominal cramping; diarrhea; nausea; hot and cold sweats; hot and cold sweats; 99.1F temperature; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 08Apr2021 at 11:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included family history of Irritable Bowel Syndrome (IBS), heart disease and cancer and the patient was diagnosed with depression and anxiety and was allergic to red onions. Concomitant medications included propranolol (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN), drospirenone, ethinylestradiol betadex clathrate (YAZ) and bupropion (MANUFACTURER UNKNOWN), all taken from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 23:45, 12 hours after the vaccination, the patient experienced 40 minutes of extreme abdominal cramping, diarrhea, nausea, hot and cold sweats and 99.1 Fahrenheit temperature followed by fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event abdominal cramps was resolved on 09Apr2021, while the outcome of the events diarrhea, nausea, hot and cold sweats and 99.1 Fahrenheit temperature followed by fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Musculoskeletal stiffness, Pain, Somnolence, Thinking abnormal
Clinical narrative: EXTREME BODY STIFFNESS; BODY PAIN THROUGHOUT; FORGETFULNESS; FUZZY THINKING; SLEPT 12 OUT OF 17 HOURS.; This is a spontaneous report from a contactable consumer. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 16Mar2021 at 15:15 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 22:00 the patient experienced sleepy (slept 12 out of 17 hours), extreme body stiffness (stiffness), body pain throughout (general body pain), forgetfulness(forgetfulness) and fuzzy thinking (abnormal thinking). No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events experienced sleepy (slept 12 out of 17 hours),extreme body stiffness (stiffness), body pain throughout (general body pain), forgetfulness(forgetful) and fuzzy thinking (abnormal thinking) were resolving at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Headache, Nausea, Pain
Clinical narrative: Fever; body aches; cough congestion; headache; nausea; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, asthma, fruit allergy (citrus fruits) and penicillin allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 08:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient previously took Morphine and Codeine and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 10:00, the patient experienced fever, body aches, cough congestion, headache, nausea and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, body aches, cough congestion, headache, nausea and diarrhea were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; body aches; cough congestion; headache; nausea; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, asthma, fruit allergy (citrus fruits) and penicillin allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 08:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient previously took Morphine and Codeine and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 10:00, the patient experienced fever, body aches, cough congestion, headache, nausea and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, body aches, cough congestion, headache, nausea and diarrhea were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vaccination site pain
Clinical narrative: Pain at the injection site/tenderness to the touch at injection; headache; nausea; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 04:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient did not take other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 00:00, the patient experienced pain at the injection site, tenderness to the touch at injection site, headache, nausea, fatigue. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain at the injection site, tenderness to the touch at injection site, headache, nausea, fatigue was resolving.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Joint warmth, Musculoskeletal stiffness, Pain
Clinical narrative: Started getting excruciating joint pain; Stiffness; Knees and elbows get warm; Shoulders and hips hurt so badly; Shoulders and hips hurt so badly; Have extreme fatigue; Pain is debilitating; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727), via an unspecified route of administration on 19Mar2021 at 10:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included systemic lupus and rheumatoid arthritis. The patient did not have any allergies to medications, food or other products. Concomitant medications included labetalol (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, after the first dose, the patient started getting excruciating joint pain and stiffness, knees and elbows get warm, shoulders and hips hurt so badly and had extreme fatigue. The patient was concerned and the pain is debilitating. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events started getting excruciating joint pain and stiffness, knees and elbows get warm, shoulder and hips hurt so badly, extreme fatigue and pain is debilitating were not resolved at the time of reporting. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Tingling; Arms and hands going numb; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6207) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 13:00 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, high blood pressure , erythema multiforme and known allergy to sulfa. Concomitant medications included prednisone (MANUFACTURER UNKNOWN), nortriptyline (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN); all for unspecified indication from an unknown date. The patient previously took codeine (MANUFACTURER UNKNOWN) for unspecified indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 00:00, the patient had been having tingling and the arms and hands went numb at night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingling, arms and hands gone numb were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Fatigue, Headache, Hypoaesthesia
Clinical narrative: pain in the arm; Numbness on my left side at times; Diarrhea; stomach upset; Headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 at 13:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN), vitamin D (MANUFACTURER UNKNOWN) and budesonide inhaler (MANUFACTURER UNKNOWN) all from unknown dates and for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. It was reported that, the patient still had antibodies as of Feb2021. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 07:00, the patient experienced pain in the arm, numbness on left side at times, diarrhea, stomach upset, headache and fatigue. Therapeutic measures were not taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events pain in the arm, numbness on left side at times, diarrhea, stomach upset, headache and fatigue was resolved in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in the arm; Numbness on my left side at times; Diarrhea; stomach upset; Headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 at 13:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN), vitamin D (MANUFACTURER UNKNOWN) and budesonide inhaler (MANUFACTURER UNKNOWN) all from unknown dates and for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. It was reported that, the patient still had antibodies as of Feb2021. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 07:00, the patient experienced pain in the arm, numbness on left side at times, diarrhea, stomach upset, headache and fatigue. Therapeutic measures were not taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events pain in the arm, numbness on left side at times, diarrhea, stomach upset, headache and fatigue was resolved in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: Sore arm; A little achy in back; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm right on 08Apr2021 (at the age of 71-year-old) as a single dose for COVID-19 immunisation.  Medical history included rheumatic fever as a child, chronic allergy and sulfonamide allergy (sulfa drugs). Concomitant medications included chlorphenamine maleate, pseudoephedrine hydrochloride, ibuprofen (ADVIL ALLERGY SINUS) for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 16Mar2021 at 12:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 18:00 the patient experienced sore arm and a little achy in back. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm and a little achy in back were recovered on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.